SEC Comment Letter for Brainsway Ltd. (BWAY, BRSYF) (CIK 0001505065) (BWAY) — Oct 4, 2021
Brainsway Ltd. (BWAY, BRSYF) (CIK 0001505065)
Date: Oct. 4, 2021 · CIK: 0001505065 · Accession: 0000000000-21-012032
AI Filing Summary & Sentiment
File numbers found in text: 333-259610
Letter
United States securities and exchange commission logo October 4, 2021 Scott Areglado Chief Financial Officer Brainsway Ltd. 19 Hartum Street Bynet Building, 3rd Floor Har HaHotzvim Jerusalem, 9777518, Israel Re:Brainsway Ltd. Registration Statement on Form F-3 Filed September 17, 2021 File No. 333-259610 Dear Mr. Areglado: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Michael Davis at 202-551-4385 or Jeffrey Gabor at 202-551-2544 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Oded Bejarano
Show Raw Text
United States securities and exchange commission logo
October 4, 2021
Scott Areglado
Chief Financial Officer
Brainsway Ltd.
19 Hartum Street
Bynet Building, 3rd Floor
Har HaHotzvim
Jerusalem, 9777518, Israel
Re:Brainsway Ltd.
Registration Statement on Form F-3
Filed September 17, 2021
File No. 333-259610
Dear Mr. Areglado:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Michael Davis at 202-551-4385 or Jeffrey Gabor at 202-551-2544 with
any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Oded Bejarano